Altering the immune response with lipid-based nanoparticles.

  title={Altering the immune response with lipid-based nanoparticles.},
  author={Dalit Landesman-Milo and Dan Peer},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  volume={161 2},
Lipid-based nanoparticles (LNPs) hold great promise as delivery vectors in the treatment of cancer, inflammation, and infections and are already used in clinical practice. Numerous strategies based on LNPs are being developed to carry drugs into specific target sites. The common denominator for all of these LNPs-based platforms is to improve the payloads' pharmacokinetics, biodistribution, stability and therapeutic benefit, and to reduce to minimal adverse effects. In addition, the delivery… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS